KCNQ2 Gene Seizures Benign Neonatal Type 1 NGS Genetic DNA Test
Introduction
The KCNQ2 Gene Seizures Benign Neonatal Type 1 NGS Genetic DNA Test is an advanced diagnostic tool designed to identify genetic mutations in the KCNQ2 gene that can lead to benign neonatal seizures. This test utilizes Next-Generation Sequencing (NGS) technology, allowing for a comprehensive analysis of the genetic material.
Importance of the Test
Neonatal seizures can be distressing for both the infant and the family. Understanding the genetic basis of these seizures is crucial for effective management and treatment. The KCNQ2 test provides valuable insights that can guide healthcare professionals in making informed decisions regarding patient care.
What the Test Measures
This genetic test specifically measures mutations in the KCNQ2 gene, which are associated with benign neonatal seizures. By analyzing the DNA, the test can confirm or rule out genetic predispositions to neurological disorders.
Who Should Consider This Test?
Parents and caregivers of infants experiencing seizures, particularly those diagnosed with benign neonatal seizures, should consider this test. Symptoms that may prompt testing include:
- Recurrent seizures in newborns
- Seizures occurring within the first few days of life
- Family history of epilepsy or seizure disorders
Risk factors include a known history of genetic disorders in the family.
Benefits of Taking the Test
- Provides clarity on the genetic causes of seizures.
- Facilitates early intervention and personalized treatment plans.
- Offers reassurance to families regarding the prognosis of their child.
- Aids in genetic counseling and family planning.
Understanding Your Results
Results from the KCNQ2 Gene Seizures test will be interpreted by a qualified genetic counselor or neurologist. A positive result indicates the presence of a mutation that may contribute to the seizures, while a negative result can help rule out genetic causes. It is important to discuss the implications of the results with a healthcare provider.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| KCNQ2 Gene Seizures Benign Neonatal Type 1 NGS Genetic DNA Test | 400000 NGN | 560000 NGN |
Book the Test
To schedule your KCNQ2 Gene Seizures Benign Neonatal Type 1 NGS Genetic DNA Test, please call or WhatsApp us at +2348077798758. Our team is ready to assist you with the booking process and any inquiries you may have.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The test requires a sample type of blood or extracted DNA, or one drop of blood on an FTA card. It is recommended to have a clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected by KCNQ2 Gene Seizures.
For more information, feel free to reach out to our genetics department, where our neurologists are available to assist you.
